- Home
- TECX vs DIAX Comparison
TECX vs DIAX Comparison
Compare TECX & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- DIAX
- Stock Information
- Founded
- TECX 2019
- DIAX 2005
- Country
- TECX United States
- DIAX United States
- Employees
- TECX N/A
- DIAX N/A
- Industry
- TECX
- DIAX Finance Companies
- Sector
- TECX
- DIAX Finance
- Exchange
- TECX Nasdaq
- DIAX Nasdaq
- Market Cap
- TECX 647.7M
- DIAX 557.9M
- IPO Year
- TECX 2018
- DIAX N/A
- Fundamental
- Price
- TECX $44.89
- DIAX $15.39
- Analyst Decision
- TECX Strong Buy
- DIAX
- Analyst Count
- TECX 5
- DIAX 0
- Target Price
- TECX $72.25
- DIAX N/A
- AVG Volume (30 Days)
- TECX 140.0K
- DIAX 96.6K
- Earning Date
- TECX 11-07-2024
- DIAX 01-01-0001
- Dividend Yield
- TECX N/A
- DIAX 7.93%
- EPS Growth
- TECX N/A
- DIAX N/A
- EPS
- TECX N/A
- DIAX N/A
- Revenue
- TECX N/A
- DIAX N/A
- Revenue This Year
- TECX N/A
- DIAX N/A
- Revenue Next Year
- TECX N/A
- DIAX N/A
- P/E Ratio
- TECX N/A
- DIAX N/A
- Revenue Growth
- TECX N/A
- DIAX N/A
- 52 Week Low
- TECX $1.40
- DIAX $12.80
- 52 Week High
- TECX $48.63
- DIAX $15.12
- Technical
- Relative Strength Index (RSI)
- TECX 61.61
- DIAX 65.03
- Support Level
- TECX $37.50
- DIAX $15.14
- Resistance Level
- TECX $48.63
- DIAX $15.33
- Average True Range (ATR)
- TECX 3.47
- DIAX 0.15
- MACD
- TECX -0.63
- DIAX 0.02
- Stochastic Oscillator
- TECX 66.40
- DIAX 90.22
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Dow Jones Industrial Average by investing in an equity portfolio that seeks to substantially replicate the price movements of the DJIA, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio.